Please login to the form below

Not currently logged in
Email:
Password:

Cardiovascular outcomes

This page shows the latest Cardiovascular outcomes news and features for those working in and with pharma, biotech and healthcare.

UK’s NICE recommends anti-cholesterol Leqvio for high-risk patients

UK’s NICE recommends anti-cholesterol Leqvio for high-risk patients

primary hypercholesterolaemia or mixed dyslipidaemia who have already had a cardiovascular event such as a heart attack or stroke. ... In highlighting the lack of long-term evidence of the drug’s effect on cardiovascular outcomes, NICE also announced a

Latest news

More from news
Approximately 1 fully matching, plus 133 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Prof Sir Mike Richards joins Incisive Health as senior counsel Prof Sir Mike Richards joins Incisive Health as senior counsel

    In July 2012 he was appointed as Director for Reducing Premature Mortality on the NHS Commissioning Board (now NHS England), where he led the development of a cardiovascular outcomes strategy. ... These are vital attributes if the NHS is to navigate the

  • Teva's Mark Salyer joins Amarin Teva's Mark Salyer joins Amarin

    Salyer’s appointment comes at a key juncture for Amarin as it awaits next year’s publication of results from the REDUCE-IT cardiovascular outcomes trial.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • World Heart Day 2020: It's time to make our clinical trials more inclusive World Heart Day 2020: It's time to make our clinical trials more inclusive

    Disparities in cardiovascular health outcomes between different ethnic groups. Despite the progress that’s been made in treating heart disease, there is still a huge difference in mortality between white people ... Health outcomes are also related to

  • A new vision for tackling key illnesses

    It also looks at other areas, such as cardiovascular and respiratory conditions, and explains how the NHS plans to change its approach in order to drive improvements in patient care and ... outcomes. Cardiovascular disease (CVD). Cardiovascular disease

  • Conference research case study

    Our client had recently conducted a series of clinical trials with its breakthrough cardiovascular product, resulting in outcomes data which had the potential to give it a more competitive edge and ... Communication strategies and marketing messages were

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors...

Latest intelligence

Five big changes in the healthcare comms landscape
The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....